结直肠癌多学科综合治疗新进展

被引:2
作者
徐静
孙秀华
高冲
机构
[1] 大连医科大学附属第二医院肿瘤内科
关键词
结直肠肿瘤; 综合疗法;
D O I
暂无
中图分类号
R735.3 [肠肿瘤];
学科分类号
100214 ;
摘要
近年来,肿瘤多学科综合治疗的疗效得到了广泛的认可,由于结直肠癌治疗手段多样化,技术相对成熟,当前对结直肠癌的治疗最能体现肿瘤多学科综合治疗的治疗模式。综合治疗的方式多样化,辅助放化疗的疗效已经获得多个临床试验的验证,其他如中医中药、射频消融术、肝动脉灌注治疗等手段同样参与了综合治疗,提供了可观的疗效。
引用
收藏
页码:699 / 702
相关论文
共 14 条
[1]   术后复发直肠癌同期放化疗与单纯放疗的随机临床研究 [J].
李莎 ;
田种泽 ;
岳养军 ;
薛龙 ;
朱向辉 ;
陈小华 ;
石万萍 .
中华临床医师杂志(电子版), 2012, 6 (06) :1421-1424
[2]   结直肠癌综合治疗的规范化实施 [J].
王锡山 .
中国实用外科杂志, 2010, 30 (04) :260-264
[3]   Adjuvant Chemotherapy With FOLFOX for Primary Colorectal Cancer Is Associated With Increased Somatic Gene Mutations and Inferior Survival in Patients Undergoing Hepatectomy for Metachronous Liver Metastases [J].
Andreou, Andreas ;
Kopetz, Scott ;
Maru, Dipen M. ;
Chen, Su S. ;
Zimmitti, Giuseppe ;
Brouquet, Antoine ;
Shindoh, Junichi ;
Curley, Steven A. ;
Garrett, Christopher ;
Overman, Michael J. ;
Aloia, Thomas A. ;
Vauthey, Jean-Nicolas .
ANNALS OF SURGERY, 2012, 256 (04) :642-650
[4]  
Adjuvant Therapy With Fluorouracil and Oxaliplatin in Stage II and Elderly Patients (between ages 70 and 75 years) With Colon Cancer: Subgroup Analyses of the Multicenter International Study of Oxaliplatin, Fluorouracil, and Leucovorin in the Adjuvant Treatment of Colon Cancer Trial[J] . Christophe Tournigand,Thierry André,Franck Bonnetain,Benoist Chibaudel,Gérard Lledo,Tamas Hickish,Josep Tabernero,Corrado Boni,Jean-Baptiste Bachet,Luis Teixeira,Aimery de Gramont.Journal of Clinical Oncology .
[5]  
The efficacy of Chinese herbal medicine as an adjunctive therapy for colorectal cancer: A systematic review and meta-analysis[J] . Linda L.D. Zhong,Hai-Yong Chen,William C.S. Cho,Xiao-ming Meng,Yao Tong.Complementary Therapies in Medicine . 2012 (4)
[6]   Progression Following Neoadjuvant Systemic Chemotherapy May Not Be a Contraindication to a Curative Approach for Colorectal Carcinomatosis [J].
Passot, Guillaume ;
Vaudoyer, Delphine ;
Cotte, Eddy ;
You, Benoit ;
Isaac, Sylvie ;
Gilly, Francois Noel ;
Mohamed, Faheez ;
Glehen, Olivier .
ANNALS OF SURGERY, 2012, 256 (01) :125-129
[7]  
Adjuvant Chemotherapy With or Without Pelvic Radiotherapy After Simultaneous Surgical Resection of Rectal Cancer With Liver Metastases: Analysis of Prognosis and Patterns of Recurrence[J] . Ho Jung An,Chang Sik Yu,Sung-Cheol Yun,Byung Woog Kang,Yong Sang Hong,Jae-Lyun Lee,Min-Hee Ryu,Heung Moon Chang,Jin Hong Park,Jong Hoon Kim,Yoon-Koo Kang,Jin Cheon Kim,Tae Won Kim.International Journal of Radiation Oncology, Biology, Physics . 2012 (1)
[8]  
Role of systemic chemotherapy in the management of resected or resectablecolorectal liver metastases: a systematic review and meta-analysis of randomizedcontrolled trials[J] . Domenico Ciliberto,Ubaldo Prati,Laura Roveda,Vito Barbieri,Nicoletta Staropoli,Alberto Abbruzzese,Michele Caraglia,Massimo Di Maio,Domenico Flotta,Pierfrancesco Tassone,Pierosandro Tagliaferri.Oncology Reports . 2012 (6)
[9]  
The Treatment of Peritoneal Carcinomatosis of Colorectal Cancer with Complete Cytoreductive Surgery and Hyperthermic Intraperitoneal Peroperative Chemotherapy (HIPEC) with Oxaliplatin: A Belgian Multicentre Prospective Phase II Clinical Study[J] . Daphne Hompes,André D’Hoore,Eric Cutsem,Steffen Fieuws,Wim Ceelen,Marc Peeters,Kurt Speeten,Claude Bertrand,Hugues Legendre,Joseph Kerger.Annals of Surgical Oncology . 2012 (7)
[10]  
Radiofrequency ablation for colorectal liver metastases: prognostic factors in non-surgical candidates[J] . Ayumi Hamada,Koichiro Yamakado,Atsuhiro Nakatsuka,Junji Uraki,Masataka Kashima,Haruyuki Takaki,Takashi Yamanaka,Yasuhiro Inoue,Masato Kusunoki,Kan Takeda.Japanese Journal of Radiology . 2012 (7)